Previous Article | Next Article ![]()
Journal of Bacteriology, September 2000, p. 4987-4991, Vol. 182, No. 17
Laboratory of Clinical Investigation,
National Institute of Allergy and Infectious Diseases, National
Institutes of Health, Bethesda, Maryland 20892
Received 6 April 2000/Accepted 1 June 2000
The RHO1 homologue of Cryptococcus
neoformans complemented Saccharomyces cerevisiae rho1
mutations. The results of overexpression and site-specific mutagenesis
of CnRHO1 in C. neoformans and S. cerevisiae indicated that although CnRHO1 could
functionally substitute for the RHO1 gene of S. cerevisiae, mutants of cnrho1 manifested unique
features in certain aspects.
The Rho GTPases belong to the
Ras-related superfamily of small G proteins, which function as
molecular switches between the active, GTP-bound form and the inactive,
GDP-bound form (for reviews, see references 14, 33,
and 34). In Saccharomyces cerevisiae, RHO1 is essential (26) and Rho1p is localized at
the cell periphery, at the bud growing site (37). Rho1p
interacts with various proteins which are important for cell wall
synthesis and actin organization. The genetic and biochemical evidence
demonstrates that Rho1p interacts with and activates protein kinase C
(Pkc1p), which maintains cell wall integrity through the activation of
the mitogen-activated protein kinase cascade (19, 31).
Rom7p/Bem4p, which is related to bud emergence, has been identified as
a downstream target of Rho1p (15). Rho1p may control the
actin cytoskeleton by binding Bni1p (12, 21). Bni1p is the
yeast homologue of the mammalian proteins called formins, which
participate in morphogenesis (12). Rho1p was also identified
as the putative regulatory subunit of The fungal cell wall confers cells with rigidity and protects them from
osmotic pressure. It consists mainly of Cloning of the CnRHO1 gene.
A
temperature-sensitive strain of S. cerevisiae (HNY21,
MATa ura3 leu2 trp1 his3 ade2
rho1-104ts; a gift from E. Cabib) was transformed with
a cDNA library of C. neoformans constructed in an S. cerevisiae vector, pGAD10. Three transformants, which were able to
grow at 37°C, were obtained (data not shown). This result suggested
that a cloned cDNA of C. neoformans could functionally
suppress the temperature-sensitive mutation rho1-104 in
S. cerevisiae. The sequence of the cloned C. neoformans cDNA insert showed great similarity to the
RHO1 gene of S. cerevisiae and was almost
identical to the published sequence of CnRHO1 cDNA of
C. neoformans, which was obtained by PCR amplification
(35). The differences between the cloned cDNA and the
published CnRHO1 cDNA sequence were at positions 266 (T Effects of CnRHO1 mutations in S. cerevisiae.
Since the cDNA of CnRHO1 could function in
S. cerevisiae, we constructed a variety of mutations in the
cDNA of CnRHO1 to further study its function in S. cerevisiae. The first type of mutations was nucleotide
substitution mutations in the phosphate and magnesium binding sites,
which are similar to those in other deregulated GTPases (3).
We generated two site-specific mutations, cnrho1-Q64L and
cnrho1-G15V, which produce constitutively active
rho1 mutants in several different organisms. Three alleles,
cDNA of CnRHO1, cnrho1-Q64L, and
cnrho1-G15V, were placed under the control of a
GAL1 promoter and expressed in S. cerevisiae
strain HNY21. When transformants containing these plasmids were grown
on glucose, they exhibited a temperature-sensitive phenotype, similar
to the vector control (Fig. 1A, columns
1, 2, and 3 versus column 4). In the presence of galactose,
transformation with the wild-type CnRHO1 did not affect the
growth of yeast cells at 30°C (Fig. 1A, column 1). This observation
was different from the previously reported result in which
overexpression of S. cerevisiae RHO1 under the control of a
GAL1 promoter caused growth arrest in yeast (11).
Cells transformed with cnrho1-Q64L were not able to grow on
galactose medium (Fig. 1A, column 2). This growth arrest phenotype of
cnrho1-Q64L was similar to that of the rho1-Q68L
phenotype of S. cerevisiae (31). These results
suggested that the effect of overexpression of CnRHO1
alleles in S. cerevisiae is similar but not identical to
that of RHO1 alleles in S. cerevisiae. We noted
that the growth of yeast cells was slightly reduced when cnrho1-G15V was overexpressed in S. cerevisiae at
30°C (Fig. 1A, column 3). This observation differed from the effect
of a similar mutation in rho1 of S. pombe, in
which overexpression of rho1-G15V caused growth arrest
(1). Despite the slight reduction in growth at 30°C,
cnrho1-G15V-containing transformants were the only strains which could grow at 37°C on galactose medium (Fig. 1A, column 3),
while overexpression of CnRHO1 and cnrho1-Q64L
failed to suppress the temperature-sensitive phenotype of HNY21 at
37°C.
0021-9193/00/$04.00+0
Properties of Various RHO1 Mutant
Alleles of Cryptococcus neoformans
![]()
ABSTRACT
Top
Abstract
Text
References
![]()
TEXT
Top
Abstract
Text
References
-1,3-glucan synthase, which
produces a major structural component of the yeast cell wall (10,
32). The regulation of
-1,3-glucan synthesis by Rho1p has also
been demonstrated in Schizosaccharomyces pombe
(1) and Candida albicans (22).
-glucans, mannoproteins, and
small amounts of chitin (4, 7, 13). Among these components,
-1,3-glucan is the major component of many fungal cell walls. From
studies with S. cerevisiae, it has been demonstrated that
-1,3-glucan synthase is composed of at least one large integral
membrane catalytic subunit and a small loosely membrane-associated
regulatory subunit (16, 20, 29). The catalytic subunit has
been suggested to be encoded by FKS1 and FKS2
(9, 16, 28). The regulatory subunit is encoded by
RHO1 (10, 27, 32). Recently, sequence analysis of
the Cryptococcus neoformans RHO1 cDNA (CnRHO1)
indicated that the putative protein encoded by CnRHO1
contains 197 amino acids and shares a high degree of sequence identity
with Rho1p in other fungal species (35). The function of
CnRHO1 in C. neoformans, however, was not
elucidated. C. neoformans is an important fungal pathogen
that causes meningoencephalitis, primarily in immunocompromised patients (25). Since the regulation of glucan synthase by
CnRHO1 has not yet been established, it is of interest to
study the roles of CnRHO1 in C. neoformans.
C) and 500 (G
C) (35). This discrepancy may be attributed to
the different strains which were used to construct the cDNAs. The cloned cDNA, however, encoded the same 21.7-kDa putative protein as the
published cDNA sequence and hybridized to a single 7.0-kb BamHI fragment of genomic DNA from C. neoformans
(data not shown). By comparing the cDNA and genomic sequences, we found
that the CnRHO1 gene contains seven introns. Most of the
introns exhibit the consensus splice donor (GTNNGY) and acceptor (YAG),
except that the splice donor of intron 6 is GTCCCT. The
details for construction of all the plasmids in this study are
available upon request.

View larger version (30K):
[in a new window]
FIG. 1.
(A) Overexpression of CnRHO1 alleles in
S. cerevisiae. Different alleles of CnRHO1 were
placed under the control of the GAL1 promoter and expressed
in the HNY21 strain background. Transformants were grown as indicated.
Column 1, GAL1(p)::CnRHO1; column 2, GAL1(p)::cnrho1-Q64L; column 3, GAL1(p)::cnrho1-G15V; column 4, vector.
(B) Expression of CnRHO1 effector mutants in S. cerevisiae. Different alleles of CnRHO1 were placed
under the control of the native S. cerevisiae RHO1 promoter
and terminator. The resulting plasmids were transformed into a
rho1 strain of S. cerevisiae, as described in
the text. Transformants were incubated at either room temperature (RT)
or 37°C. Column 1, RHO1(p)::CnRHO1;
column 2, RHO1(p)::cnrho1-V39T;
column 3, RHO1(p)::cnrho1-E41I. (C)
Overexpression of CnRHO1 in C. neoformans.
Different alleles of CnRHO1 were placed under the control of
the C. neoformans GAL7 promoter and transformed into the LP1
strain. Transformants were grown as indicated. Column 1, GAL1(p)::CnRHO1; column 2, GAL7(p)::cnrho1-Q64L; column 3, GAL1(p)::cnrho1-G15V; column 4, vector.
Gal + Pne, galactose medium with 128 µg of pneumocandin
B0/ml. (D) Phenotypes of TYCC314 and TYCC295. Replacing the
CnRHO1 allele with the cnrho1-E41I allele
in C. neoformans generated a temperature-sensitive phenotype
(TYCC314). B-4476-FO5 is a congenic strain containing wild-type
CnRHO1. The temperature-sensitive phenotype of TYCC314 was
suppressed by 1 M sorbitol. Reconstitution of cnrho1-E41I
back to the wild-type allele restored growth at 37°C (TYCC295).
Overexpression of CnRHO1 in C. neoformans. Since overexpression of the deregulated mutations of cnrho1 cDNA in S. cerevisiae resulted in interesting phenotypes, we attempted to determine the effects of constitutively active mutations of CnRHO1 on the growth of C. neoformans. Three cDNA clones, CnRHO1, cnrho1-Q64L, and cnrho1-G15V, were placed under the control of the C. neoformans GAL7 promoter. The resulting constructs were transformed into an ade2 ura5 recipient strain (LP1). PCRs were performed to confirm the existence of unaltered fusion constructs by using specific primers which were designed to detect the GAL7-CnRHO1 fusion construct (data not shown). PCR-positive transformants were transferred onto galactose medium to overexpress each construct of CnRHO1. Unlike the results of overexpression of CnRHO1 in S. cerevisiae described above, growth of C. neoformans at either 30 or 37°C was not affected when CnRHO1 was overexpressed (Fig. 1C, column 1). The growth of transformants containing cnrho1-Q64L was greatly reduced on galactose medium, but these transformants were still viable at either 30 or 37°C (Fig. 1C, column 2). In contrast, overexpression of cnrho1-G15V did not affect growth of C. neoformans at either temperature (Fig. 1C, column 3). These results showed that the effects of overexpression of CnRHO1, as well as overexpression of deregulated cnrho1 alleles, in C. neoformans are different from those in S. cerevisiae.
S. pombe is hypersensitive to the glucan synthase inhibitor papulacandin B when RHO1 is overexpressed (1). Pneumocandin lipopeptides are a class of compounds also known to inhibit
-1,3-glucan synthesis (8, 24). C. neoformans, however, is notably less susceptible to these
inhibitors (2, 17, 23). We tested whether overexpression of
CnRHO1 could cause hypersensitivity to pneumocandin
B0. The presence of up to 128 µg of pneumocandin B0 per ml had no obvious effect on growth in a strain
overexpressing CnRHO1 or cnrho1-G15V, while
pneumocandin B0 slightly exacerbated the retarded growth in
cells overexpressing the cnrho1-Q64L allele (Fig. 1C,
Gal + Pne). Thus, C. neoformans was resistant to
pneumocandin B0 even when CnRHO1 was
overexpressed. Another interesting observation was that when
CnRHO1 cDNA was expressed in a rho1 deletion
mutant of S. cerevisiae, the resulting strain was as
sensitive as control strains to pneumocandin B0 (data not shown).
Glucan synthase activity in strains overexpressing
CnRHO1.
Since the
-1,3-glucan-specific fluorochrome
aniline blue poorly stains Cryptococcus cells, it has been
suggested that
-1,3-glucan is not prevalent in
Cryptococcus cell walls (31). This observation is
further supported by chemical analysis of cell wall components (18). On the other hand, a different study suggests that
CnFKS1, which may encode a
-1,3-glucan synthase catalytic
subunit, may be required for the viability of C. neoformans
(37). As glucan synthase activity of many fungi is regulated
by RHO1p, it was of interest to study the relationship between RHO1p
and glucan synthase in C. neoformans. To determine whether
CnRHO1 could modulate glucan synthase activity, glucan
synthase activity was determined using the membrane fraction of
C. neoformans cells in which various alleles of
CnRHO1 had been overexpressed. Enzyme activity was quantitated by measuring the incorporation of UDP-glucose into a
trichloroacetic acid-insoluble fraction, as described previously (36) but with modifications. The reaction mixtures contained crude membrane fraction, 50 mM Tris (pH 7.5), 10% glycerol, 0.5 mM
EDTA, 25 mM KF, 0.25% (wt/vol) bovine serum albumin, 20 µM [
-S]GTP, UDP-[14C]glucose (specific activity, 319 mCi/mmol; Amersham) and 10 mM unlabeled UDP-glucose (specific activity,
250,000 cpm/µmol). After 2 h of incubation with gentle
agitation, reactions were terminated with ice-cold trichloroacetic
acid. Glucan synthase activity was expressed as nanomoles per milligram
per hour. Glucan synthase activity (mean ± standard deviation)
decreased 39.7% in transformants containing only the vector when GTP
was excluded from the reaction mixture (55.7 ± 2.1 versus
33.6 ± 6.2). Thus, as in other fungi, the glucan synthase
activity of C. neoformans was affected by the presence of
GTP. In cryptococcal transformants overexpressing the wild-type
CnRHO1 allele, glucan synthase activity in the presence or
absence of GTP (61.6 ± 9.3 versus 36.8 ± 5.1) was not
significantly different from that of the corresponding vector control.
In contrast, the effect of the presence of GTP on glucan synthase
activity was much lower in strains overexpressing the activated mutant alleles cnrho1-Q64L (61.4 ± 3.4 versus 51.8 ± 6.1; 15.6% reduction) and cnrho1-G15V (57.9 ± 1.9 versus 52.3 ± 0.4; 9.7% reduction). These results suggested
that, as observed with S. cerevisiae (32), when
cells overexpressed the deregulated cnrho1 alleles, addition of exogenous GTP to the reaction had little influence on the activity of glucan synthase.
Construction of a temperature-sensitive RHO1 allele in
C. neoformans.
We attempted to delete the CnRHO1
gene in C. neoformans, with no success (data not shown). It
is likely that CnRHO1 is an essential gene, as is the case
in other organisms. Since cnrho1-E41I cDNA behaved as a
temperature-sensitive allele in S. cerevisiae, we
anticipated that a replacement of the wild-type CnRHO1 gene with a cnrho1-E41I allele in the genome of C. neoformans might generate a temperature-sensitive phenotype. The
cnrho1-E41I mutation was generated in vitro and was used to
construct a replacement plasmid, pYCC314 (Fig. 2B). Plasmid pYCC314 was
transformed into C. neoformans, and transformants were
selected by a positive-negative selection method to obtain cells
containing a gene replacement (5). A PCR screening method
was applied by using insertion-specific primers to identify putative
transformants, which presumably carry the replacement plasmid at the
CnRHO1 locus (Fig. 2B).
Southern blot analysis was then used to confirm the integration of
cnrho1-E41I at the CnRHO1 locus by a gene
replacement event. Figure 2F shows that a 7.0-kb wild-type
CnRHO1 fragment was replaced with a 10-kb fragment in
TYCC314 due to homologous integration, as depicted in Fig. 2C.
|
Nucleotide sequence accession number. The GenBank accession number for the genomic sequence of CnRHO1 is AF242351.
| |
ACKNOWLEDGMENTS |
|---|
We thank E. Cabib and A. Varma for helpful suggestions and critical reading of the manuscript. We are indebted to K. J. Kwon-Chung for strong support and guidance, which facilitated this study.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Building 10, Room 11C304, National Institutes of Health, Bethesda, MD 20892. Phone: (301) 496-1238. Fax: (301) 402-1003. E-mail: yc3z{at}nih.gov.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Arellano, M., A. Duran, and P. Perez. 1996. Rho 1 GTPase activates the (1-3)-beta-D-glucan synthase and is involved in Schizosaccharomyces pombe morphogenesis. EMBO J. 15:4584-4591[Medline]. |
| 2. |
Bartizal, K.,
G. Abruzzo,
C. Trainor,
D. Krupa,
K. Nollstadt,
D. Schmatz,
R. Schwartz,
M. Hammond,
J. Balkovec, and F. Vanmiddlesworth.
1992.
In vitro antifungal activities and in vivo efficacies of 1,3- -D-glucan synthesis inhibitors L-671,329, L-646,991, tetrahydroechinocandin B, and L-687,781, a papulacandin.
Antimicrob. Agents Chemother.
36:1648-1657 |
| 3. | Bourne, H. R., D. A. Sanders, and F. McCormick. 1991. The GTPase superfamily: conserved structure and molecular mechanism. Nature 349:117-127[CrossRef][Medline]. |
| 4. |
Chaffin, W. L.,
J. L. López-Ribot,
M. Casanova,
D. Gozalbo, and J. P. Martínez.
1998.
Cell wall and secreted proteins of Candida albicans: identification, function, and expression.
Microbiol. Mol. Biol. Rev.
62:130-180 |
| 5. |
Chang, Y. C., and K. J. Kwon-Chung.
1994.
Complementation of a capsule-deficient mutation of Cryptococcus neoformans restores its virulence.
Mol. Cell. Biol.
14:4912-4919 |
| 6. |
Chang, Y. C.,
B. L. Wickes,
G. F. Miller,
L. A. Penoyer, and K. J. Kwon-Chung.
2000.
Cryptococcus neoformans STE12 regulates virulence but is not essential for mating.
J. Exp. Med.
191:871-882 |
| 7. |
Cid, V. J.,
A. Durán,
F. del Rey,
M. P. Snyder,
C. Nombela, and M. Sánchez.
1995.
Molecular basis of cell integrity and morphogenesis in Saccharomyces cerevisiae.
Microbiol. Rev.
59:345-386 |
| 8. | Debono, M., and R. S. Gordee. 1994. Antibiotics that inhibit fungal cell wall development. Annu. Rev. Microbiol. 48:471-497[CrossRef][Medline]. |
| 9. |
Douglas, C. M.,
F. Foor,
J. A. Marrinan,
N. Morin,
J. B. Nielsen,
A. M. Dahl,
P. Mazur,
W. Baginsky,
W. Li,
M. el-Sherbeini, et al.
1994.
The Saccharomyces cerevisiae FKS1 (ETG1) gene encodes an integral membrane protein which is a subunit of 1,3-beta-D-glucan synthase.
Proc. Natl. Acad. Sci. USA
91:12907-12911 |
| 10. | Drgonova, J., T. Drgon, K. Tanaka, R. Kollar, G. C. Chen, R. A. Ford, C. S. Chan, Y. Takai, and E. Cabib. 1996. Rho1p, a yeast protein at the interface between cell polarization and morphogenesis. Science 272:277-279[Abstract]. |
| 11. | Espinet, C., M. A. de la Torre, M. Aldea, and E. Herrero. 1995. An efficient method to isolate yeast genes causing overexpression-mediated growth arrest. Yeast 11:25-32[CrossRef][Medline]. |
| 12. |
Evangelista, M.,
K. Blundell,
M. S. Longtine,
C. J. Chow,
N. Adames,
J. R. Pringle,
M. Peter, and C. Boone.
1997.
Bni1p, a yeast formin linking cdc42p and the actin cytoskeleton during polarized morphogenesis.
Science
276:118-122 |
| 13. | Fleet, G. H. 1985. Composition and structure of yeast cell walls. Curr. Top. Med. Mycol. 1:24-56[Medline]. |
| 14. | Hariharan, I. K., K. Q. Hu, H. Asha, A. Quintanilla, R. M. Ezzell, and J. Settleman. 1995. Characterization of rho GTPase family homologues in Drosophila melanogaster: overexpressing Rho1 in retinal cells causes a late developmental defect. EMBO J. 14:292-302[Medline]. |
| 15. | Hirano, H., K. Tanaka, K. Ozaki, H. Imamura, H. Kohno, T. Hihara, T. Kameyama, K. Hotta, M. Arisawa, T. Watanabe, H. Qadota, Y. Ohya, and Y. Takai. 1996. ROM7/BEM4 encodes a novel protein that interacts with the Rho1p small GTP-binding protein in Saccharomyces cerevisiae. Mol. Cell. Biol. 16:4396-4403[Abstract]. |
| 16. | Inoue, S. B., N. Takewaki, T. Takasuka, T. Mio, M. Adachi, Y. Fujii, C. Miyamoto, M. Arisawa, Y. Furuichi, and T. Watanabe. 1995. Characterization and gene cloning of 1,3-beta-D-glucan synthase from Saccharomyces cerevisiae. Eur. J. Biochem. 231:845-854[Medline]. |
| 17. | Iwata, K., Y. Yamamoto, H. Yamaguchi, and T. Hiratani. 1982. In vitro studies of aculeacin A, a new antifungal antibiotic. J. Antibiot. (Tokyo) 35:203-209[Medline]. |
| 18. | James, P. G., R. Cherniak, R. G. Jones, C. A. Stortz, and E. Reiss. 1990. Cell-wall glucans of Cryptococcus neoformans Cap 67. Carbohydr. Res. 198:23-38[CrossRef][Medline]. |
| 19. |
Kamada, Y.,
H. Qadota,
C. P. Python,
Y. Anraku,
Y. Ohya, and D. E. Levin.
1996.
Activation of yeast protein kinase C by Rho1 GTPase.
J. Biol. Chem.
271:9193-9196 |
| 20. |
Kang, M. S., and E. Cabib.
1986.
Regulation of fungal cell wall growth: a guanine nucleotide-binding, proteinaceous component required for activity of (1-3)-beta-D-glucan synthase.
Proc. Natl. Acad. Sci. USA
83:5808-5812 |
| 21. | Kohno, H., K. Tanaka, A. Mino, M. Umikawa, H. Imamura, T. Fujiwara, Y. Fujita, K. Hotta, H. Qadota, T. Watanabe, Y. Ohya, and Y. Takai. 1996. Bni1p implicated in cytoskeletal control is a putative target of Rho1p small GTP binding protein in Saccharomyces cerevisiae. EMBO J. 15:6060-6068[Medline]. |
| 22. |
Kondoh, O.,
Y. Tachibana,
Y. Ohya,
M. Arisawa, and T. Watanabe.
1997.
Cloning of the RHO1 gene from Candida albicans and its regulation of -1,3-glucan synthesis.
J. Bacteriol.
179:7734-7741 |
| 23. | Krishnarao, T. V., and J. N. Galgiani. 1997. Comparison of the in vitro activities of the echinocandin LY303366, the pneumocandin MK-0991, and fluconazole against Candida species and Cryptococcus neoformans. Antimicrob. Agents Chemother. 41:1957-1960[Abstract]. |
| 24. | Kurtz, M. B., and C. M. Douglas. 1997. Lipopeptide inhibitors of fungal glucan synthase. J. Med. Vet. Mycol. 35:79-86[Medline]. |
| 25. | Kwon-Chung, K. J., and J. E. Bennett. 1992. Medical mycology, p. 397-446. Lea & Febiger, Philadelphia, Pa. |
| 26. |
Madaule, P.,
R. Axel, and A. M. Myers.
1987.
Characterization of two members of the rho gene family from the yeast Saccharomyces cerevisiae.
Proc. Natl. Acad. Sci. USA
84:779-783 |
| 27. |
Mazur, P., and W. Baginsky.
1996.
In vitro activity of 1,3-beta-D-glucan synthase requires the GTP-binding protein Rho1.
J. Biol. Chem.
271:14604-14609 |
| 28. |
Mazur, P.,
N. Morin,
W. Baginsky,
M. el-Sherbeini,
J. A. Clemas,
J. B. Nielsen, and F. Foor.
1995.
Differential expression and function of two homologous subunits of yeast 1,3- -D-glucan synthase.
Mol. Cell. Biol.
15:5671-5681[Abstract].
|
| 29. |
Mol, P. C.,
H. M. Park,
J. T. Mullins, and E. Cabib.
1994.
A GTP-binding protein regulates the activity of (1 3)-beta-glucan synthase, an enzyme directly involved in yeast cell wall morphogenesis.
J. Biol. Chem.
269:31267-31274 |
| 30. |
Nicholas, R.,
D. Williams, and P. Hunter.
1994.
Investigation of the value of -glucan specific fluorochromes for predicting the -glucan content of cell walls of zoopathogenic fungi.
Mycol. Res.
98:694-698.
|
| 31. | Nonaka, H., K. Tanaka, H. Hirano, T. Fujiwara, H. Kohno, M. Umikawa, A. Mino, and Y. Takai. 1995. A downstream target of RHO1 small GTP-binding protein is PKC1, a homolog of protein kinase C, which leads to activation of the MAP kinase cascade in Saccharomyces cerevisiae. EMBO J. 14:5931-5938[Medline]. |
| 32. | Qadota, H., C. P. Python, S. B. Inoue, M. Arisawa, Y. Anraku, Y. Zheng, T. Watanabe, D. E. Levin, and Y. Ohya. 1996. Identification of yeast Rho1p GTPase as a regulatory subunit of 1,3-beta-glucan synthase. Science 272:279-281[Abstract]. |
| 33. | Symons, M. 1996. Rho family GTPases: the cytoskeleton and beyond. Trends Biochem. Sci. 21:178-181[CrossRef][Medline]. |
| 34. | Takai, Y., T. Sasaki, K. Tanaka, and H. Nakanishi. 1995. Rho as a regulator of the cytoskeleton. Trends Biochem. Sci. 20:227-231[CrossRef][Medline]. |
| 35. | Tanaka, K., H. Nambu, Y. Katoh, M. Kai, and Y. Hidaka. 1999. Molecular cloning of homologs of RAS and RHO1 genes from Cryptococcus neoformans. Yeast 15:1133-1139[CrossRef][Medline]. |
| 36. |
Thompson, J. R.,
C. M. Douglas,
W. Li,
C. K. Jue,
B. Pramanik,
X. Yuan,
T. H. Rude,
D. L. Toffaletti,
J. R. Perfect, and M. Kurtz.
1999.
A glucan synthase FKS1 homolog in Cryptococcus neoformans is single copy and encodes an essential function.
J. Bacteriol.
181:444-453 |
| 37. |
Yamochi, W.,
K. Tanaka,
H. Nonaka,
A. Maeda,
T. Musha, and Y. Takai.
1994.
Growth site localization of Rho1 small GTP-binding protein and its involvement in bud formation in Saccharomyces cerevisiae.
J. Cell Biol.
125:1077-1093 |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»